BFCH Closes Ancient Extracts USA Acquisition, Accelerating UNLOCKD's Transition Into a Scalable Consumer Wellness Operating Platform
BitFrontier Capital Holdings (BFCH) finalizes the acquisition of Ancient Extracts USA, adding an established wellness platform with DTC and retail infrastructure, marking a pivotal step in its strategy to build a scalable multi-brand operating platform in the wellness sector.
BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., announced today the successful closing of its acquisition of VerdaGenix, LLC, the owner and operator of the Ancient Extracts USA wellness platform. The transaction positions the company to accelerate its transition from a concept-driven entity into a scalable operating platform focused on wellness, performance, and human optimization.
With the closing complete, Ancient Extracts USA becomes a wholly owned subsidiary of BFCH, bringing with it an established direct-to-consumer (DTC) infrastructure, proprietary formulations, intellectual property, supplier relationships, inventory, fulfillment capabilities, and a diversified catalog of over 20 wellness SKUs already commercialized and in market. Management believes this acquisition significantly de-risks the company's broader strategy by providing an active commercial foundation that can support future growth initiatives.
The acquisition follows a series of strategic developments over the past year, including the elimination of more than $2 million in legacy convertible debt, strengthening of the balance sheet, restoration of disclosure compliance, acquisition of the EVERMIND™ intellectual property platform, and expansion of executive leadership. These moves reflect BFCH's commitment to building a robust operating platform capable of long-term value creation.
Management stated that the company is now actively transitioning Ancient Extracts into a broader commercialization and expansion phase, focusing on scaling both DTC operations and retail distribution opportunities. BFCH confirmed that it is advancing strategic growth capital initiatives to support inventory expansion, operational scaling, customer acquisition, and retail channel development.
John P. Gorst, CEO of BFCH, emphasized the importance of acquiring an already-operating business. “We are not attempting to create a concept from scratch. Ancient Extracts already has operating infrastructure, commercialized products, existing customers, active distribution channels, and a brand foundation capable of meaningful expansion,” he said. “Our focus now is execution, commercialization scale, and building a significantly larger operating platform around assets we believe possess real long-term value.”
Jordan P. Balencic, D.O., Chairman and Chief Science Officer, echoed this sentiment, calling the closing a “transformational milestone.” He noted that the company is still in the early stages of building a platform centered around wellness, performance, and cognitive health. “Our focus now shifts from corporate restructuring and platform assembly toward commercialization, operational execution, strategic expansion, and long-term value creation,” Dr. Balencic said.
The company expects to announce additional operational milestones, including retail initiatives, strategic partnerships, purchase order activity, and expanded distribution opportunities. Management believes the market is underestimating the scale of the opportunity being assembled and is focused on aggressively but intelligently expanding distribution and strengthening operations.
Separately, BFCH recently received a formal legal opinion concluding that it is not a shell company under Rule 405 of the Securities Act of 1933, based on its operating strategy, asset base, and ongoing activities. For more information, visit www.UNLOCKDinc.com and view current filings on OTC Markets.